Exposome Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-05-2024
- Paid Up Capital ₹ 0.10 M
as on 22-05-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1337.31%
(FY 2022)
- Profit 26.52%
(FY 2022)
- Ebitda 30.25%
(FY 2022)
- Net Worth -74.12%
(FY 2022)
- Total Assets 568.45%
(FY 2022)
About Exposome
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Goradia and Prerna Goradia serve as directors at the Company.
- CIN/LLPIN
U46691MH2020PTC340395
- Company No.
340395
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Exposome Private Limited offer?
Exposome Private Limited offers a wide range of products and services, including Raw and Processed Leather, Animal Leather, Filter Assemblies and Spare Parts, Filter Cloth.
Who are the key members and board of directors at Exposome?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prerna Goradia  | Director | 07-Jun-2020 | Current |
| Amit Goradia | Director | 07-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Exposome.
Exposome Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1337.31% increase. The company also saw a substantial improvement in profitability, with a 26.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 74.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Exposome?
Unlock access to Exposome's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Electropneumatics Cnc Controls Private LimitedActive 9 years 10 monthsAmit Goradia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Exposome?
Exposome has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exposome, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exposome's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
